JPH11506017A5 - - Google Patents

Info

Publication number
JPH11506017A5
JPH11506017A5 JP1997519267A JP51926797A JPH11506017A5 JP H11506017 A5 JPH11506017 A5 JP H11506017A5 JP 1997519267 A JP1997519267 A JP 1997519267A JP 51926797 A JP51926797 A JP 51926797A JP H11506017 A5 JPH11506017 A5 JP H11506017A5
Authority
JP
Japan
Prior art keywords
treatment
mab
ior
generalized
jelly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997519267A
Other languages
English (en)
Japanese (ja)
Other versions
JP4113929B2 (ja
JPH11506017A (ja
Filing date
Publication date
Priority claimed from CU1995120A external-priority patent/CU22584A1/es
Application filed filed Critical
Publication of JPH11506017A publication Critical patent/JPH11506017A/ja
Publication of JPH11506017A5 publication Critical patent/JPH11506017A5/ja
Application granted granted Critical
Publication of JP4113929B2 publication Critical patent/JP4113929B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51926797A 1995-11-17 1996-11-18 アンチｃｄ６モノクロナール抗体とその利用 Expired - Lifetime JP4113929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU1995120A CU22584A1 (es) 1995-11-17 1995-11-17 Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis
CU120/95 1995-11-17
PCT/CU1996/000004 WO1997019111A2 (es) 1995-11-17 1996-11-18 Anticuerpos monoclonales anti-cd6 y sus utilizaciones

Publications (3)

Publication Number Publication Date
JPH11506017A JPH11506017A (ja) 1999-06-02
JPH11506017A5 true JPH11506017A5 (cg-RX-API-DMAC10.html) 2008-03-13
JP4113929B2 JP4113929B2 (ja) 2008-07-09

Family

ID=5459401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51926797A Expired - Lifetime JP4113929B2 (ja) 1995-11-17 1996-11-18 アンチｃｄ６モノクロナール抗体とその利用

Country Status (15)

Country Link
US (1) US6572857B1 (cg-RX-API-DMAC10.html)
EP (1) EP0807125B1 (cg-RX-API-DMAC10.html)
JP (1) JP4113929B2 (cg-RX-API-DMAC10.html)
KR (1) KR100533854B1 (cg-RX-API-DMAC10.html)
CN (1) CN1222540C (cg-RX-API-DMAC10.html)
AT (1) ATE280783T1 (cg-RX-API-DMAC10.html)
AU (1) AU722882B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI9607171B1 (cg-RX-API-DMAC10.html)
CA (1) CA2210751C (cg-RX-API-DMAC10.html)
CU (1) CU22584A1 (cg-RX-API-DMAC10.html)
DE (1) DE69633717T2 (cg-RX-API-DMAC10.html)
DK (1) DK0807125T3 (cg-RX-API-DMAC10.html)
ES (1) ES2231826T3 (cg-RX-API-DMAC10.html)
PT (1) PT807125E (cg-RX-API-DMAC10.html)
WO (1) WO1997019111A2 (cg-RX-API-DMAC10.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266604A1 (en) * 2000-05-26 2001-12-11 Smith Kline Beecham Corporation Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
CU23097A1 (es) * 2002-10-23 2005-11-18 Centro Inmunologia Molecular Método para la obtención de líneas celulares en medio libre de proteína y líneas celulares obtenidas por este método
EP1597275B1 (en) 2003-02-24 2010-08-18 Institut Pasteur Use of the Chlamydia pneumoniae CPn0104 polypeptide or antibodies thereto to diagnose Chlamydia infections
PL2119452T3 (pl) * 2006-12-26 2021-03-08 Centro De Inmunologia Molecular Kompozycja farmaceutyczna zawierająca przeciwciało monoklonalne anty-cd6 do zastosowania w diagnostyce i leczeniu reumatoidalnego zapalenia stawów
CN101678101B (zh) 2006-12-26 2012-11-07 分子免疫中心 可用于诊断和治疗b细胞慢性淋巴细胞白血病的能够在肿瘤细胞中诱导凋亡的药物组合物
MX2010007551A (es) 2008-01-11 2010-11-30 Synovex Corp Antagonistas de la cadherina-11 y metodos para el tratamiento de trastornos inflamatorios de las articulacion.
BRPI0822447A2 (pt) * 2008-03-14 2015-06-16 Biocon Ltd Anticorpo monoclonal e método do mesmo
HRP20180563T1 (hr) * 2010-07-15 2018-06-15 Adheron Therapeutics, Inc. Humanizirana protutijela koja ciljaju ec1 domenu kadherina-11 i odgovarajući pripravci i postupci
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DE19177059T1 (de) 2010-10-01 2021-10-07 Modernatx, Inc. N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
AU2012279225A1 (en) 2011-07-01 2014-01-16 Beckman Coulter, Inc. Regulatory T cells and methods of identifying, obtaining and using to treat immuno-based disorders
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
HUE057725T2 (hu) 2011-10-03 2022-06-28 Modernatx Inc Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
HRP20220717T1 (hr) 2011-12-16 2022-07-22 Modernatx, Inc. Modificirani pripravci mrna
JP2015516143A (ja) 2012-04-02 2015-06-08 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
SMT202200337T1 (it) 2012-11-26 2022-09-14 Modernatx Inc Rna modificato al livello del terminale
FR3000216B1 (fr) * 2012-12-21 2015-02-06 Galderma Res & Dev Utilisation de proteases particulieres pour la detection de trichophytons et de pathologies associees
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP3738613A1 (en) 2013-07-23 2020-11-18 Biocon Limited Use of a cd6 binding partner and method based thereon
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
WO2015051214A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
CN105504062B (zh) * 2015-12-25 2019-06-04 百泰生物药业有限公司 一种抗CD6单抗T1h的检测性抗体及应用
ES2991182T3 (es) 2016-10-21 2024-12-02 Biocon Ltd Un anticuerpo monoclonal y un método de uso para el tratamiento del lupus
JP7572041B2 (ja) * 2018-02-27 2024-10-23 エクイリウム，インコーポレイテッド 重症喘息を処置するための組成物および方法
US12281151B2 (en) 2018-06-29 2025-04-22 City Of Hope CD6 targeted chimeric antigen receptors for treatment of certain autoimmune disorders
BR112021016967A2 (pt) 2019-02-26 2021-11-23 Equillium Inc Composições de anticorpo anti-cd6 e métodos para tratar lúpus
WO2021138454A1 (en) 2019-12-30 2021-07-08 City Of Hope Methods of making and using regulatory t cells and effector t cells having chimeric antigen receptors targeted to cd6, cd19, and/or an il-13r for treatment of autoimmune disorders and cancers
US20230151107A1 (en) * 2020-04-04 2023-05-18 Biocon Limited Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19
KR20240055093A (ko) 2021-09-08 2024-04-26 센트로 데 인뮤놀러지아 모레큘러 과다 염증 반응으로 인한 세포 및 장기 손상 예방을 위한 항-cd6 단일클론항체의 용도
WO2025096685A1 (en) 2023-10-30 2025-05-08 City Of Hope Methods of making and using regulatory t cells for treatment of autoimmune disorders and cancers
CN120005027B (zh) * 2025-04-10 2025-09-23 中国水产科学研究院长江水产研究所 大口黑鲈cd6抗原结合肽、及其单克隆抗体和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726912A4 (en) * 1993-11-02 2000-08-23 Univ Duke Cd6 ligand
CU22615A1 (es) * 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos

Similar Documents

Publication Publication Date Title
JPH11506017A5 (cg-RX-API-DMAC10.html)
Hart et al. Indomethacin: a new non-steroid anti-inflammatory agent
CA2129541A1 (en) Method of Promoting Nitrogen Retention in Humans
AU664492B2 (en) Method and composition for treating inflammatory bowel disorders
KR920000324A (ko) 필수 지방산 처리법
Perkins Apnea with intramuscular colistin therapy
Seedat et al. Acute renal failure due to proliferative nephritis from snake bite poisoning
US4369190A (en) Analgesic composition and use thereof to ameliorate intractable pain
US4678668A (en) Method of reducing soft tissue swelling and pain
JPH0585523B2 (cg-RX-API-DMAC10.html)
EP0055118A1 (en) Arthritis treatment
US5331012A (en) Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
US3636202A (en) Treatment of rheumatoid arthritis and related diseases
US4119713A (en) Analgesic and anti-inflammatory composition
US5716646A (en) Methods and compositions for treating arthritis
RU96115219A (ru) Способ лечения больных сахарным диабетом
Neary et al. Development of extrapyramidal symptoms in hypertensive patients treated with diazoxide
Furniss Nonsteroidal anti-inflammatory agents in the treatment of primary dysmenorrhea
RU2182006C2 (ru) Способ лечения ревматоидного артрита
RU95102611A (ru) Способ лечения туберкулеза легких
RU94000695A (ru) Средство с противоаллергическим действием
Yu et al. Creatine derivatives: rapid complete relief of pain by topical or transcutaneous administration
MICHELSON et al. Treatment of cutaneous tuberculosis with large doses of vitamin D2
Lee Age-related changes in gastric mucosal bicarbonate secretion in rats
Stone et al. VITAMIN B AND E THERAPY IN TABES DORSALIS:(Preliminary Report on the Use of Wheat Germ Oil, Vitamin B Complex and Intraspinal Administration of Thiamin Chloride)